West Paces Advisors’s AtriCure ATRC Stock Holding History

West Paces Advisors’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-25	Closed	-$807	–	227
2025 Q1	$807	Hold	25	–	–	﹤0.01%	507
2024 Q4	$764	Hold	25	–	–	﹤0.01%	505
2024 Q3	$701	Hold	25	–	–	﹤0.01%	499
2024 Q2	$569	Hold	25	–	–	﹤0.01%	525
2024 Q1	$761	Hold	25	–	–	﹤0.01%	529
2023 Q4	$892	Hold	25	–	–	﹤0.01%	516
2023 Q3	$1.09K	Hold	25	–	–	﹤0.01%	460
2023 Q2	$1.23K	Hold	25	–	–	﹤0.01%	483
2023 Q1	$1.04K	Hold	25	–	–	﹤0.01%	507
2022 Q4	$1.11K	Hold	25	–	–	﹤0.01%	468
2022 Q3	$978	Hold	25	–	–	﹤0.01%	469
2022 Q2	$1.02K	Hold	25	–	–	﹤0.01%	520
2022 Q1	$1.64K	Hold	25	–	–	﹤0.01%	495
2021 Q4	$1.74K	Hold	25	–	–	﹤0.01%	528
2021 Q3	$1.74K	Hold	25	–	–	﹤0.01%	525
2021 Q2	$1.98K	Hold	25	–	–	﹤0.01%	541
2021 Q1	$1.64K	Hold	25	–	–	﹤0.01%	417
2020 Q4	$1.39K	Hold	25	–	–	﹤0.01%	401
2020 Q3	$998	Buy	+25	New	+$1.06K	﹤0.01%	402

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

West Paces Advisors's ATRC Position: Q2 2025 in Review

West Paces Advisors sold out of AtriCure (ATRC) in Q2 2025, closing a stake of 25 shares — an estimated $807 sold.

West Paces Advisors first reported a position in ATRC in Q3 2020 and held it in 19 quarters. The position peaked at $1.98K in Q2 2021. 201 funds tracked by Wall St. Rank hold ATRC as of Q2 2025.

West Paces Advisors reported no remaining AtriCure position as of Q2 2025 after selling out during the quarter.
West Paces Advisors sold 25 AtriCure shares in Q2 2025, an estimated $807.
West Paces Advisors first reported a position in AtriCure in Q3 2020 and held it in 19 quarters.
West Paces Advisors's AtriCure position peaked at $1.98K in Q2 2021.
201 funds tracked by Wall St. Rank held AtriCure as of Q2 2025.

Based on West Paces Advisors's 13F filing for Q2 2025, filed 23 Jul 2025.